Long-acting injectable medicine as potential route to COVID-19 therapy

Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19. In a paper published in the journal Nanoscale, researchers from the University’s Centre of Excellence for Long-acting Therapeutics (CELT) demonstrate the nanoparticle formulation of niclosamide, a…

Details

New imaging technique captures how brain moves in stunning detail, holds diagnostic potential

Magnetic Resonance Imaging (MRI) images are usually meant to be static. But now, researchers from Mātai Medical Research Institute (Mātai), Stevens Institute of Technology, Stanford University, the University of Auckland and other institutions, report on an imaging technique that captures the brain in motion in real time, in 3D and in stunning detail, providing a…

Details

ASN Foundation announces recipients of National Scientific Achievement Awards

The American Society for Nutrition (ASN) and the ASN Foundation are proud to announce the 2021 recipients of its scientific achievement awards. “The 2021 ASN award recipients are an esteemed group of scientists whose contributions and dedication to advancing nutrition research, education and practice are inspiring,” stated ASN President, Lindsay Allen, PhD. “We are thrilled…

Details

Nanoscope presents novel gene delivery and electrophysiology platforms at ARVO

ARLINGTON, TX (May 5, 2021) — Nanoscope Technologies LLC, a biotechnology company developing gene therapies for treatment of retinal diseases, is featuring multiple scientific presentations highlighting its groundbreaking research on optical gene delivery for vision restoration and OCT-guided electrophysiology platforms for characterization of retinal degeneration and assessment of efficacy of cell-gene therapy at the 2021…

Details